Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort.

@article{Wijburg2019PerformanceOP,
  title={Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort.},
  author={Martijn T. Wijburg and Clemens Warnke and Frederik Barkhof and Bernard Uitdehaag and Joep Killestein and Mike P. Wattjes},
  journal={Journal of neurology, neurosurgery, and psychiatry},
  year={2019},
  volume={90 1},
  pages={
          44-46
        }
}
OBJECTIVE To test the current progressive multifocal leukoencephalopathy (PML) diagnostic criteria by applying them to patients previously diagnosed with natalizumab (NTZ)-associated PML in a real-world clinical setting. METHODS Patients from the Dutch-Belgian NTZ-PML cohort (n=28) were reviewed at the time of first diagnostic work-up and during follow-up, using the PML diagnostic criteria as proposed in a consensus statement from the American Academy of Neurology. RESULTS At first… CONTINUE READING
11
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-3 OF 3 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.

  • Journal of neurology, neurosurgery, and psychiatry
  • 2016
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

MRI pattern in asymptomatic natalizumab-associated PML.

  • Journal of neurology, neurosurgery, and psychiatry
  • 2015
VIEW 1 EXCERPT

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

  • Annals of clinical and translational neurology
  • 2014
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…